RSS Updates
Email Updates
ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16.
Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25.
Popular Inc (BPOP) Concerns bank could fail.
Douglas A. McIntyre
Posts for Ticker ‘NSIT’
The 52-Week Low Club
-
Today’s top tickerspy Indexes Bill Collector St... +9.1% Airline Stocks +5.3% Vehicle Rental St... +5.1% Home Furnishing R... +4.5% Gold and Silver S... +4.2% 
-
-
-
-
- Celebrity Site iFollo Gets $1 Million
- AP Stories Reappear on Google News; "Ongoing Discussions"
- Baidu Credits New Ad System For Better Than Expected Results
- Disney's Iger Takes Big Swig Of iPad Kool-Aid
- RealNetworks, MTVN To Spin Off Rhapsody; Real Gives Up Control
- SEC Watch: SpinVox CEO Used Company 'As A Current Account' While Clocking Up Massive Losses
-
©2010 24/7 Wall St.
Powered by WordPress.com VIP
Designed by SlipFire
